Skip to main content
OpenTrials
Completed

NCT Number: NCT06317584

Empowerment-based Complementary and Alternative Medicine (ECAM)

This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHENG GUNG MEMORIAL HOSPITAL, Linkou

Taoyuan City, Guishan District, 333, Taiwan

About this study

The objectives of this phase study are to (1) implement the ECAM educational app to empower patients with diabetes in their management of diabetes alongside CAM use; (2) examine the impact of the ECAM educational app on patient empowerment, CAM health literacy, risk management of CAM use, CAM communication and diabetes quality of life in patients with diabetes; and (3) collect feedback from both patients and nurses on how to improve the ECAM educational app for dissemination and implementation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People over the age of 20
  • diagnosis of diabetes at least 12 months before the interview; and
  • The use of CAM at least 3 months
  • Sufficient mental ability to understand the informed consent form and sign it.

Exclusion criteria

  • Participants will be excluded by an assistant researcher if they serious physical condition and hard of hearing and seeing.

Treatment and study plan

Experimental: Empowerment Application for CAM Health Education

Other

Using empowerment software application for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of assistive tool of the empowerment software application

Written Paper for CAM Health Education

Other

Using written paper for complementary and alternative therapy education and explaining the risk factors that need to be considered

Primary outcomes

  1. Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire

    Time frame: Pre-test (baseline), 2, 3 months after intervention

    Measure patients' understanding of benefit-risk management on CAM use,The lower the score, the poorer the understanding.

  2. Quality of life questionnaire

    Time frame: Pre-test (baseline), 2, 3 months after intervention

    assess patients' satisfaction with various aspects of life while managing diabetes.

  3. Diabetes Empowerment scale

    Time frame: Pre-test (baseline), 2, 3 months after intervention

    Measure patients' understanding of benefit-risk management on CAM use, the minimum and maximum values,and higher scores .The minimum is 10,maximum values is 40,The lower the score, the poorer the understanding.

Sponsors and collaborators

Lead sponsor

Chang Gung University of Science and Technology

Other

Collaborators

  • Chang Gung Memorial Hospital
  • National Science and Technology Council

Registry information

Official study title

The Establishment of "Empowerment-based Complementary and Alternative Medicine (ECAM) " Educational Program to Improve Complementary and Alternative Medicine(CAM) Health Literacy in Patients With Diabetes: Dilemma Analysis, Integration Into Practice and Outcome Evaluation

Acronym: CAM

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Mar 19, 2024
Registry last updated
Apr 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.